Hydrocodone Bitartrate

酒石酸氢可酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrocodone Bitartrate
Drug Alias Name酒石酸二氢可待因酮Vantrela ERHysingla ERZohydro ERCEP-33237 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsSubstance-Related DisordersChronic PainLow Back Pain +[8] 
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryCanada
Original Approved Date1991/01/01
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPurdue Pharma
Inactive CompaniesPurdue Pharma LpEgalet LtdTeva Branded Pharmaceutical Products R&D Inc +[7] 
Active IndicationsChronic PainPain
Inactive IndicationsSubstance-Related DisordersLow Back PainRenal Insufficiency +[6] 

Other Information

ATC CodeR05DA03
Related LinksWikipediaDrugBankKEGG